1. Home
  2. RCMT vs GNFT Comparison

RCMT vs GNFT Comparison

Compare RCMT & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCMT
  • GNFT
  • Stock Information
  • Founded
  • RCMT 1971
  • GNFT 1999
  • Country
  • RCMT United States
  • GNFT France
  • Employees
  • RCMT N/A
  • GNFT N/A
  • Industry
  • RCMT Professional Services
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RCMT Consumer Discretionary
  • GNFT Health Care
  • Exchange
  • RCMT Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • RCMT 200.2M
  • GNFT 216.7M
  • IPO Year
  • RCMT N/A
  • GNFT 2019
  • Fundamental
  • Price
  • RCMT $19.11
  • GNFT $4.24
  • Analyst Decision
  • RCMT Strong Buy
  • GNFT Strong Buy
  • Analyst Count
  • RCMT 2
  • GNFT 2
  • Target Price
  • RCMT $33.50
  • GNFT $10.00
  • AVG Volume (30 Days)
  • RCMT 35.1K
  • GNFT 9.4K
  • Earning Date
  • RCMT 11-05-2025
  • GNFT 09-22-2025
  • Dividend Yield
  • RCMT N/A
  • GNFT N/A
  • EPS Growth
  • RCMT N/A
  • GNFT N/A
  • EPS
  • RCMT 1.71
  • GNFT N/A
  • Revenue
  • RCMT $309,840,000.00
  • GNFT $52,994,715.00
  • Revenue This Year
  • RCMT $15.03
  • GNFT $3.14
  • Revenue Next Year
  • RCMT $7.49
  • GNFT N/A
  • P/E Ratio
  • RCMT $11.38
  • GNFT N/A
  • Revenue Growth
  • RCMT 13.70
  • GNFT N/A
  • 52 Week Low
  • RCMT $13.18
  • GNFT $2.55
  • 52 Week High
  • RCMT $28.27
  • GNFT $4.79
  • Technical
  • Relative Strength Index (RSI)
  • RCMT 27.22
  • GNFT 54.62
  • Support Level
  • RCMT $18.93
  • GNFT $4.10
  • Resistance Level
  • RCMT $23.36
  • GNFT $4.38
  • Average True Range (ATR)
  • RCMT 0.86
  • GNFT 0.19
  • MACD
  • RCMT -0.30
  • GNFT 0.02
  • Stochastic Oscillator
  • RCMT 18.35
  • GNFT 82.31

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: